Lv6
2495 积分 2020-12-08 加入
时间不带走一切，却留下了痕迹。
Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT
16小时前
求助中
Recent advances and research progress in biomarkers for chronic graft versus host disease
2天前
已完结
Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
2天前
已完结
Development of FABP4/5 inhibitors with potential therapeutic effect on type 2 Diabetes Mellitus
12天前
已完结
Selective ROCK2 inhibitor reverses experimental chronic graft-versus-host disease via concurrent regulation of STAT3/STAT5 phosphorylation (TRAN1P.933)
12天前
已关闭
Role of ROCK2 inhibitors in the Treatment of Chronic Graft-versus-Host disease
16天前
已完结
A First-in-Class JAK/ROCK Inhibitor, Rovadicitinib, for Glucocorticoid-Refractory or -Dependent Chronic GVHD
16天前
已完结
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
17天前
已完结
Inhibiting EZH2 function prevents and treats chronic graft vs host disease (cGVHD) by disrupting germinal center formation and plasma cell maturation
26天前
已关闭
Long-term CXCR3 antagonist AMG487 mitigated acute graft-versus-host disease by inhibiting T cell activation in a murine model
27天前
已完结
皖公网安备34019202002308
